RESUMO
Apramycin is a structurally unique member of the 2-deoxystreptamine class of aminoglycoside antibiotics characterized by a monosubstituted 2-deoxystreptamine ring that carries an unusual bicyclic eight-carbon dialdose moiety. Because of its unusual structure, apramycin is not susceptible to the most prevalent mechanisms of aminoglycoside resistance including the aminoglycoside-modifying enzymes and the ribosomal methyltransferases whose widespread presence severely compromises all aminoglycosides in current clinical practice. These attributes coupled with minimal ototoxocity in animal models combine to make apramycin an excellent starting point for the development of next-generation aminoglycoside antibiotics for the treatment of multidrug-resistant bacterial infections, particularly the ESKAPE pathogens. With this in mind, we describe the design, synthesis, and evaluation of three series of apramycin derivatives, all functionalized at the 5-position, with the goals of increasing the antibacterial potency without sacrificing selectivity between bacterial and eukaryotic ribosomes and of overcoming the rare aminoglycoside acetyltransferase (3)-IV class of aminoglycoside-modifying enzymes that constitutes the only documented mechanism of antimicrobial resistance to apramycin. We show that several apramycin-5-O-ß-d-ribofuranosides, 5-O-ß-d-eryrthofuranosides, and even simple 5-O-aminoalkyl ethers are effective in this respect through the use of cell-free translation assays with wild-type bacterial and humanized bacterial ribosomes and of extensive antibacterial assays with wild-type and resistant Gram negative bacteria carrying either single or multiple resistance determinants. Ex vivo studies with mouse cochlear explants confirm the low levels of ototoxicity predicted on the basis of selectivity at the target level, while the mouse thigh infection model was used to demonstrate the superiority of an apramycin-5-O-glycoside in reducing the bacterial burden in vivo.
Assuntos
Aminoaciltransferases/metabolismo , Antibacterianos/farmacologia , Farmacorresistência Bacteriana/efeitos dos fármacos , Glicosídeos/química , Nebramicina/análogos & derivados , Antibacterianos/química , Configuração de Carboidratos , Sequência de Carboidratos , Éteres/química , Testes de Sensibilidade Microbiana , Nebramicina/química , Nebramicina/farmacologiaRESUMO
Total synthesis of three important trehalose containing tetrasaccharides isolated from Mycobacterium smegmatis is reported for the first time, using regioselective opening of benzylidene acetals and stereoselective glycosylations as key steps. The 1,2-cis stereoselectivity in the glycosylation reactions was achieved using anchimeric assistance from a remote participating group, steric effects and solvent participation. The synthetic strategy can also be utilized for the assembly of structurally related oligosaccharides from M. tuberculosis.
Assuntos
Mycobacterium smegmatis/química , Oligossacarídeos/química , Trealose/síntese química , Configuração de Carboidratos , Oligossacarídeos/isolamento & purificação , Trealose/químicaRESUMO
Trehalose dibenzylidene and substituted dibenzylidene acetals were reductively opened either at O6 or O4 in a regioselective manner by using a DIBAL stock solution prepared in toluene or dichloromethane, respectively, to achieve desymmetrization of the trehalose core. The method was applied to synthesize various biologically important unsymmetrically substituted trehalose glycoconjugates, including a mycobacterial trisaccharide, a 4-epi-trehalosamine analog and a maradolipid.
Assuntos
Acetais/química , Compostos de Benzilideno/química , Compostos Organometálicos/química , Trealose/química , Estrutura Molecular , Oxirredução , EstereoisomerismoRESUMO
The first synthesis of maradolipid, a unique dissymmetrically 6,6'-di-O-acylated trehalose glycolipid isolated from C. elegans, is accomplished in five steps starting from trehalose in 45% overall yield. The short synthesis relies on dissymmetrization of trehalose core via regioselective acylation of a 2,3,4,2',3',4'-hexa-O-TMS trehalose 6,6'-diol derivative as a key step.
Assuntos
Glicolipídeos/síntese química , Trealose/síntese química , Acilação , Animais , Caenorhabditis elegans/química , Glicolipídeos/química , Glicolipídeos/isolamento & purificação , Dados de Sequência Molecular , Estrutura Molecular , Trealose/análogos & derivados , Trealose/químicaRESUMO
Herein, we report a strategy for the total synthesis of a structurally unique fungal glycolipid fusaroside. The first total synthesis of the proposed structure involved construction of the complex, branched lipid chain having a variety of alkenes with E stereochemistry and attachment of the masked α,ß-unsaturated ß-keto acid at the O-4 position of trehalose as key steps. We propose a revision in the structure of fusaroside, particularly the position of olefins in the lipid chain.
Assuntos
Fungos/química , Glicolipídeos/síntese química , Lipídeos/química , Alcenos/química , Glicolipídeos/química , Estrutura Molecular , Trealose/químicaRESUMO
Propylamycin (4'-deoxy-4'-propylparomomycin) is a next generation aminoglycoside antibiotic that displays increased antibacterial potency over the parent, coupled with reduced susceptibility to resistance determinants and reduced ototoxicity in the guinea pig model. Propylamycin nevertheless is inactivated by APH(3')-Ia, a specific aminoglycoside phosphotransferase isozyme that acts on the primary hydroxy group of the ribofuranosyl moiety (at the 5''-position). To overcome this problem, we have prepared and studied the antibacterial and antiribosomal activity of various propylamycin derivatives carrying amino or substituted amino groups at the 5''-position in place of the vulnerable hydroxy group. We find that the introduction of an additional basic amino group at this position, while overcoming the action of the aminoglycoside phosphoryltransferase isozymes acting at the 5''-position as anticipated, results in a significant drop in selectivity for the bacterial over the eukaryotic ribosomes that is predictive of increased ototoxicity. In contrast, 5''-deoxy-5''-formamidopropylamycin retains the excellent across-the-board levels of antibacterial activity of propylamycin itself, while circumventing the action of the offending aminoglycoside phosphotransferase isozymes and affording even greater selectivity for the bacterial over the eukaryotic ribosomes. Other modifications to address the susceptibility of propylamycin to the APH(3')-Ia isozyme including deoxygenation at the 3'-position and incorporation of a 6',5''-bis(hydroxyethylamino) modification offer no particular advantage.
Assuntos
Aminoglicosídeos , Antibacterianos , Animais , Antibacterianos/toxicidade , Cobaias , Testes de Sensibilidade Microbiana , RibossomosRESUMO
The adamantanyl thioglycosides of 5-isothiocyano and 5-azido 5-desamino-4,7,8,9-tetra-O-acetylneuraminic acid methyl ester were converted into the corresponding dibutyl phosphates, which proved to be excellent α-selective donors for O-sialidation with a range of typical acceptors, and good donors for reaction with allyltributylstannane, albeit without significant anomeric selectivity. In the KDN series the dibuylphosphate derived from a donor carrying a 4,5-cyclic carbonate protecting group afforded the corresponding C-glycoside with excellent α-selectivity on activation in the presence of allyltributylstannane, whereas the corresponding donor carrying acetate esters at the 4- and 5-positions was unselective. Overall, it is revealed that while the strongly electron-withdrawing isothiocyanato and azido groups are sufficient to promote highly α-selective O-sialidation, they are inadequate when faced with less reactive nucleophiles when mixtures of anomers are obtained.
Assuntos
Carbono/química , Oxigênio/química , Fosfatos/química , Glicosilação , Estereoisomerismo , Tioglicosídeos/químicaRESUMO
Mycobacterium tuberculosis (Mtb) serves as the epitome of how lipids-next to proteins-are utilized as central effectors in pathogenesis. It synthesizes an arsenal of structurally atypical lipids (C60-C90) to impact various membrane-dependent steps involved in host interactions. There is a growing precedent to support insertion of these exposed lipids into the host membrane as part of their mode of action. However, the vital role of specific virulence-associated lipids in modulating cellular functions by altering the host membrane organization and associated signaling pathways remain unanswered questions. Here, we combined chemical synthesis, biophysics, cell biology, and molecular dynamics simulations to elucidate host membrane structure modifications and modulation of membrane-associated signaling using synthetic Mycobacterium tuberculosis sulfoglycolipids (Mtb SL). We reveal that Mtb SL reorganizes the host cell plasma membrane domains while showing higher preference for fluid membrane regions. This rearrangement is governed by the distinct conformational states sampled by SL acyl chains. Physicochemical assays with SL analogues reveal insights into their structure-function relationships, highlighting specific roles of lipid acyl chains and headgroup, along with effects on autophagy and cytokine profiles. Our findings uncover a mechanism whereby Mtb uses specific chemical moieties on its lipids to fine-tune host lipid interactions and confer control of the downstream functions by modifying the cell membrane structure and function. These findings will inspire development of chemotherapeutics against Mtb by counteracting their effects on the host-cell membrane.
Assuntos
Membrana Celular/fisiologia , Glicolipídeos/síntese química , Glicolipídeos/metabolismo , Interações Hospedeiro-Patógeno/fisiologia , Macrófagos/fisiologia , Mycobacterium tuberculosis/metabolismo , Autofagia , Citocinas/metabolismo , Humanos , Bicamadas Lipídicas/metabolismo , Metabolismo dos Lipídeos/fisiologia , Macrófagos/citologia , Estrutura Molecular , Transdução de Sinais , Relação Estrutura-Atividade , VirulênciaRESUMO
We describe a straightforward synthesis of the apramycin biosynthetic precursor saccharocin from apramycin by regioselective partial azidation followed by stereoretentive oxidative deamination. Saccharocin was found to exhibit excellent selectivity for inhibition of the bacterial ribosome over the eukaryotic ribosomes indicating that its presence as a minor impurity in apramycin itself should not be problematic in the development of the latter as a clinical candidate.
RESUMO
A series of derivatives of the 4,5-disubstituted class of 2-deoxystreptamine aminoglycoside antibiotics neomycin, paromomycin, and ribostamycin was prepared and assayed for (i) their ability to inhibit protein synthesis by bacterial ribosomes and by engineered bacterial ribosomes carrying eukaryotic decoding A sites, (ii) antibacterial activity against wild type Gram negative and positive pathogens, and (iii) overcoming resistance due to the presence of aminoacyl transferases acting at the 2'-position. The presence of five suitably positioned residual basic amino groups was found to be necessary for activity to be retained upon removal or alkylation of the 2'-position amine. As alkylation of the 2'-amino group overcomes the action of resistance determinants acting at that position and in addition results in increased selectivity for the prokaryotic over eukaryotic ribosomes, it constitutes an attractive modification for introduction into next generation aminoglycosides. In the neomycin series, the installation of small (formamide) or basic (glycinamide) amido groups on the 2'-amino group is tolerated.
Assuntos
Aminoglicosídeos/síntese química , Aminoglicosídeos/farmacologia , Antibacterianos/síntese química , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Ribossomos/efeitos dos fármacos , Sítios de Ligação , Farmacorresistência Bacteriana Múltipla/efeitos dos fármacos , Hexosaminas , Humanos , Testes de Sensibilidade Microbiana , Neomicina/química , Neomicina/farmacologia , Paromomicina/química , Paromomicina/farmacologia , Biossíntese de Proteínas/efeitos dos fármacos , Ribossomos/metabolismo , Relação Estrutura-AtividadeRESUMO
Fungal glycolipids emmyguyacins A and B inhibit the pH-dependent conformational change of hemaglutinin A during replication of the Influenza virus. Herein, we report the first total synthesis and structure confirmation of emmyguyacins A and B. Our efficient route, which involves regioselective functionalization of trehalose, allows rapid access to adequate amounts of chemically pure emmyguyacin analogues including the desoxylate derivatives for SAR studies.
Assuntos
Glicolipídeos/síntese química , Hemaglutininas Virais/efeitos dos fármacos , Orthomyxoviridae/efeitos dos fármacos , Isomerismo , Estrutura Molecular , Oxalatos/química , Trealose/químicaRESUMO
Syntheses of the 6'- N-(2-hydroxyethyl) and 1- N-(4-amino-2 S-hydroxybutyryl) derivatives of the 4,6-aminoglycoside sisomicin and that of the doubly modified 1- N-(4-amino-2 S-hydroxybutyryl)-6'- N-(2-hydroxyethyl) derivative known as plazomicin are reported together with their antibacterial and antiribosomal activities and selectivities. The 6'- N-(2-hydroxyethyl) modification results in a moderate increase in prokaryotic/eukaryotic ribosomal selectivity, whereas the 1- N-(4-amino-2 S-hydroxybutyryl) modification has the opposite effect. When combined in plazomicin, the effects of the two groups on ribosomal selectivity cancel each other out, leading to the prediction that plazomicin will exhibit ototoxicity comparable to those of the parent and the current clinical aminoglycoside antibiotics gentamicin and tobramycin, as borne out by ex vivo studies with mouse cochlear explants. The 6'- N-(2-hydroxyethyl) modification restores antibacterial activity in the presence of the AAC(6') aminoglycoside-modifying enzymes, while the 1- N-(4-amino-2 S-hydroxybutyryl) modification overcomes resistance to the AAC(2') class but is still affected to some extent by the AAC(3) class. Neither modification is able to circumvent the ArmA ribosomal methyltransferase-induced aminoglycoside resistance. The use of phenyltriazenyl protection for the secondary amino group of sisomicin facilitates the synthesis of each derivative and their characterization through the provision of sharp NMR spectra for all intermediates.
Assuntos
Aminoglicosídeos/química , Aminoglicosídeos/farmacologia , Antibacterianos/química , Antibacterianos/farmacologia , Ribossomos/fisiologia , Sisomicina/química , Sisomicina/farmacologia , Aminoglicosídeos/síntese química , Antibacterianos/síntese química , Sequência de Bases , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Escherichia coli/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Biossíntese de Proteínas/efeitos dos fármacos , Sisomicina/síntese química , Relação Estrutura-AtividadeRESUMO
A novel methodology for the regioselective O6 acylation of the 2,3-diacyl trehaloses to access Mycobacterium tuberculosis sulfolipid SL-3 and related 2,3,6-triester glycolipid analogues is reported for the first time. The methodology was successfully extended to achieve the first total synthesis of the tetraacylated trehalose glycolipid from Mycobacterium paraffinicum. The corresponding 2,3,6'-triesters trehalose glycolipids were also synthesized starting from the common 2,3-diacyl trehalose. These synthetic glycolipids are potential candidates for serodiagnosis and vaccine development for tuberculosis.
Assuntos
Glicolipídeos/síntese química , Lipídeos/síntese química , Mycobacterium tuberculosis/química , Acilação , Glicolipídeos/química , Lipídeos/química , Estrutura Molecular , Trealose/análogos & derivados , Trealose/químicaRESUMO
M. tuberculosis sulfoglycolipids SL-1 and Ac2SGL are highly immunogenic and potential vaccine candidates. A short and efficient methodology is reported for the synthesis of SL-1 and Ac2SGL analogues via regioselective functionalization of α,α-D-trehalose employing a highly regioselective late stage sulfation, as a key step. The SL-1 analogues 3a and 4 were obtained in 10 and 9 steps in 13.4% and 23.9% overall yields, respectively. The Ac2SGL analogue 5 was synthesized in 5 steps in 18.4% yield.
Assuntos
Vacinas Bacterianas/síntese química , Vacinas Bacterianas/imunologia , Glicolipídeos/síntese química , Glicolipídeos/imunologia , Mycobacterium tuberculosis/química , Mycobacterium tuberculosis/imunologia , Trealose/química , Fatores de Virulência/síntese química , Vacinas Bacterianas/química , Glicolipídeos/química , Estrutura Molecular , Trealose/análogos & derivados , Fatores de Virulência/química , Fatores de Virulência/imunologiaRESUMO
An overview of the oxidative deamination of N-acetylneuraminic acid derivatives (Neu5Ac) leading to the formation of ketodeoxynonulosonic acid (KDN), its stereoisomers and glycosides is presented. A brief historical introduction to the deamination is given, followed by a description of recent advances in reaction conditions, which have allowed application of the process to Neu5Ac thioglycosides, and that have enabled the range of nucleophiles incorporated in the course of the reaction to be extended beyond the original acetate and azide. Recent advances resulting in derivatization of the Neu55Ac 4-position concomitant with replacement of the acetamido group, via the presumed intermediacy of a vinyl diazonium ion, are then described. The literature on the mechanism of the deamination reaction is next considered leading to the presentation of an overall mechanistic framework that accounts for all observations to date. Finally, the application of the deamination reaction to complex Neu5Ac-based oligosaccharides and other aminosugars is presented.